Testing considerations for phosphatidylinositol‐3‐kinase catalytic subunit alpha as an emerging biomarker in advanced breast cancer

por Toppmeyer, Deborah L., Press, Michael F.
Publicado 2020

Histone acetylation: novel target for the treatment of acute lymphoblastic leukemia

por Zhang, Cheng, Zhong, Jiang F., Stucky, Andres, Chen, Xue-Lian, Press, Michael F., Zhang, Xi
Publicado 2015

CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer

por Ring, Alexander, Nguyen, Cu, Smbatyan, Goar, Tripathy, Debu, Yu, Min, Press, Michael, Kahn, Michael, Lang, Julie E.
Publicado 2018

Deep learning-enabled breast cancer hormonal receptor status determination from base-level H&E stains

por Naik, Nikhil, Madani, Ali, Esteva, Andre, Keskar, Nitish Shirish, Press, Michael F., Ruderman, Daniel, Agus, David B., Socher, Richard
Publicado 2020

Clinical evaluation of BCL-2/X(L) levels pre- and post- HER2-targeted therapy

por Zoeller, Jason J., Press, Michael F., Selfors, Laura M., Dering, Judy, Slamon, Dennis J., Hurvitz, Sara A., Brugge, Joan S.
Publicado 2021

Human-derived normal mesenchymal stem/stromal cells in anticancer therapies

por Zhang, Cheng, Yang, Shi-Jie, Wen, Qin, Zhong, Jiang F, Chen, Xue-Lian, Stucky, Andres, Press, Michael F, Zhang, Xi
Publicado 2017

Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients

por Erber, Ramona, Rübner, Matthias, Davenport, Simon, Hauke, Sven, Beckmann, Matthias W., Hartmann, Arndt, Häberle, Lothar, Gass, Paul, Press, Michael F., Fasching, Peter A.
Publicado 2020

Antibody targeting facilitates effective intratumoral siRNA nanoparticle delivery to HER2-overexpressing cancer cells

por Palanca-Wessels, Maria C., Booth, Garrett C., Convertine, Anthony J., Lundy, Brittany B., Berguig, Geoffrey Y., Press, Michael F., Stayton, Patrick S., Press, Oliver W.
Publicado 2016

A Big Bang model of human colorectal tumor growth

por Sottoriva, Andrea, Kang, Haeyoun, Ma, Zhicheng, Graham, Trevor A., Salomon, Matthew P., Zhao, Junsong, Marjoram, Paul, Siegmund, Kimberly, Press, Michael F., Shibata, Darryl, Curtis, Christina
Publicado 2015

Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: Pooled results from three countries

por Jones, Michael E, van Leeuwen, Flora E, Hoogendoorn, Wilhelmina E, Mourits, Marian JE, Hollema, Harry, van Boven, Hester, Press, Michael F, Bernstein, Leslie, Swerdlow, Anthony J
Publicado 2012

The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer

por Bektas, Nuran, Noetzel, Erik, Veeck, Jürgen, Press, Michael F, Kristiansen, Glen, Naami, Amjad, Hartmann, Arndt, Dimmler, Arno, Beckmann, Matthias W, Knüchel, Ruth, Fasching, Peter A, Dahl, Edgar
Publicado 2008

Role for polo-like kinase 4 in mediation of cytokinesis

por Press, Michael F., Xie, Bin, Davenport, Simon, Zhou, Yu, Guzman, Roberta, Nolan, Garry P., O’Brien, Neil, Palazzolo, Michael, Mak, Tak W., Brugge, Joan S., Slamon, Dennis J.
Publicado 2019

Molecular Assessment of HER2 to Identify Signatures Associated with Therapy Response in HER2-Positive Breast Cancer

por Maddox, Adam L., Brehove, Matthew S., Eliato, Kiarash R., Saftics, Andras, Romano, Eugenia, Press, Michael F., Mortimer, Joanne, Jones, Veronica, Schmolze, Daniel, Seewaldt, Victoria L., Jovanovic-Talisman, Tijana
Publicado 2022

Tumor biomarkers and efficacy in patients treated with trastuzumab emtansine + pertuzumab versus standard of care in HER2-positive early breast cancer: an open-label, phase III stu...

por de Haas, Sanne L., Slamon, Dennis J., Martin, Miguel, Press, Michael F., Lewis, Gail D., Lambertini, Chiara, Prat, Aleix, Lopez-Valverde, Vanesa, Boulet, Thomas, Hurvitz, Sara A.
Publicado 2023

A Standardized Investigational Ki-67 Immunohistochemistry Assay Used to Assess High-Risk Early Breast Cancer Patients in the monarchE Phase 3 Clinical Study Identifies a Population...

por Polewski, Monika D., Nielsen, Gitte B., Gu, Ying, Weaver, Aaron T., Gegg, Gavin, Tabuena-Frolli, Siena, Cajaiba, Mariana, Hanks, Debra, Method, Michael, Press, Michael F., Gottstein, Claudia, Gruver, Aaron M.
Publicado 2022

Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis

por Serce, Nuran Bektas, Boesl, Andreas, Klaman, Irina, von Serényi, Sonja, Noetzel, Erik, Press, Michael F, Dimmler, Arno, Hartmann, Arndt, Sehouli, Jalid, Knuechel, Ruth, Beckmann, Matthias W, Fasching, Peter A, Dahl, Edgar
Publicado 2012

A careful reassessment of anthracycline use in curable breast cancer

por Hurvitz, Sara Alsterlind, McAndrew, Nicholas P., Bardia, Aditya, Press, Michael F., Pegram, Mark, Crown, John P., Fasching, Peter A., Ejlertsen, Bent, Yang, Eric H., Glaspy, John A., Slamon, Dennis J.
Publicado 2021

Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Coho...

por Haiman, Christopher A, Garcia, Rachel R, Hsu, Chris, Xia, Lucy, Ha, Helen, Sheng, Xin, Le Marchand, Loic, Kolonel, Laurence N, Henderson, Brian E, Stallcup, Michael R, Greene, Geoffrey L, Press, Michael F
Publicado 2009

Correction to: Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer

por Ring, Alexander, Campo, Daniel, Porras, Tania B., Kaur, Pushpinder, Forte, Victoria A., Tripathy, Debu, Lu, Janice, Kang, Irene, Press, Michael F., Jeong, Young Ju, Snow, Anson, Zhu, Yue, Zada, Gabriel, Wagle, Naveed, Lang, Julie E.
Publicado 2022

Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer

por Ring, Alexander, Campo, Daniel, Porras, Tania B., Kaur, Pushpinder, Forte, Victoria A., Tripathy, Debu, Lu, Janice, Kang, Irene, Press, Michael F., Jeong, Young Ju, Snow, Anson, Zhu, Yue, Zada, Gabriel, Wagle, Naveed, Lang, Julie E.
Publicado 2022